AI assistant
Sending…
OPKO Health Inc. — M&A Activity 2021
May 24, 2021
6963_rns_2021-05-24_75133e3e-a00f-47b6-b8bb-2157895427a7.htm
M&A Activity
Open in viewerOpens in your device viewer
OPKO Health Reports Transfer of Licensed Rights to RAYALDEE� in Japan to Vifor����� ���� �� ���� �� ����� ������ ������ ���� false
| ����� ���', ���� | 2 380 |
| OPKO HEALTH, INC | |
| Corporation no: 2279206 | 10018 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 24/05/2021 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2021-02-089208 | Time of broadcast: 18:37 18:37 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onOPKO Health Reports Transfer of Licensed Rights to RAYALDEE� in Japan to Vifor ����� ���� �� ���� �� ����� ������ ������ ����
20210524PR_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ GSM | Date of revision of form structure: 04/05/2021 |
| Address: Ashlegan 16 , Kiryat Gat 8211804 Israel , Tel: 08-9300051 , Fax: 08-9543101 | |
| E-mail address: [email protected] Company site: Www.Opko.Com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Benor Sharon Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: | |
| Address: Golda Meir 7 , Nes-Ziona 7414002 Telephone: 08-9300051 Facsimile: 08-9300091 E-mail: [email protected] 1 | |
More from OPKO Health Inc.
Proxy Solicitation & Information Statement
2026
May 16
Report Publication Announcement
2026
May 16
Report Publication Announcement
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 1
Report Publication Announcement
2026
May 1
Proxy Solicitation & Information Statement
2026
May 1
Proxy Solicitation & Information Statement
2026
May 1
Proxy Solicitation & Information Statement
2026
May 1
Remuneration Information
2026
May 1